The summary report on the public consultation on the revision of the general pharmaceutical legislation has been recently published.
The public consultation, launched by the European commission in 2021, aimed to collect views of different stakeholders to support the evaluation of the existing general pharmaceutical legislation on medicines for human use, and the impact assessment of its revision to ensure a future-proof and crisis-resistant medicines regulatory system.
The general pharmaceutical legislation sets the main definitions, regulatory incentives and authorisation procedures, as well as the manufacturing, authorisation and post-authorisation requirements for medicines.
Overall, 478 contributions were submitted to the public consultation by December 2021.
Six campaigns were identified by using a combination of statistical and manual approach to analyse the received responses.
Consult the full report and the received contributions here!